Black Jeffrey G. — SEC insider filings

SEC reporting owner CIK 1449439. 23 insider filings on record with FilingPulse; latest filed 2026-09-02.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2020-08-06 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Alphatec Holdings, Inc. (ATEC)EVP & CFO4—4 legs · 45,929 sh · $600,843—
Apollo Endosurgery, Inc. (APEN)Chief Financial Officer64 legs · 65,000 sh · $447,850—10
EXAGEN INC. (XGN)Chief Financial Officer71 leg · 22,298 sh · $66,4483 legs · 42,664 sh · $354,8627
STANDARD BIOTOOLS INC. (LAB)SVP & Chief Financial Officer62 legs · 85,984 sh · $193,578—11

Insider filings — Black Jeffrey G.

FiledFormIssuerReported transactionsSource
2026-09-024EXAGEN INC. (XGN)Sale (S): 20,614 @ $7.22 · Grant/award (A): 1,571 @ $3.02EDGAR
2026-03-164EXAGEN INC. (XGN)Grant/award (A): 75,000 @ $3.16 · Grant/award (A): 1,511 @ $3.08 · Grant/award (A): 50,000 (derivative) @ $3.16EDGAR
2026-02-254EXAGEN INC. (XGN)Sale (S): 1,584 @ $3.61EDGAR
2025-09-044EXAGEN INC. (XGN)Sale (S): 20,466 @ $9.79EDGAR
2025-02-254EXAGEN INC. (XGN)Grant/award (A): 15,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $3.58EDGAR
2024-11-194EXAGEN INC. (XGN)Purchase (P): 22,298 @ $2.98EDGAR
2024-09-054STANDARD BIOTOOLS INC. (LAB)Tax withholding (F): 6,690 @ $1.91EDGAR
2024-09-044EXAGEN INC. (XGN)Grant/award (A): 225,000 @ $0EDGAR
2024-08-194STANDARD BIOTOOLS INC. (LAB)Option exercise (M): 13,157 @ $0 · Tax withholding (F): 4,695 @ $1.55 · Option exercise (M): 13,157 (derivative) @ $0EDGAR
2024-05-214STANDARD BIOTOOLS INC. (LAB)Grant/award (A): 300,000 @ $0 · Grant/award (A): 400,000 (derivative) @ $0EDGAR
2024-05-164STANDARD BIOTOOLS INC. (LAB)Option exercise (M): 52,631 @ $0 · Tax withholding (F): 18,779 @ $2.54 · Option exercise (M): 52,631 (derivative) @ $0EDGAR
2023-05-224STANDARD BIOTOOLS INC. (LAB)Purchase (P): 43,492 @ $2.22 · Purchase (P): 42,492 @ $2.29EDGAR
2023-05-174STANDARD BIOTOOLS INC. (LAB)Grant/award (A): 210,526 (derivative) @ $0 · Grant/award (A): 400,000 (derivative) @ $0EDGAR
2023-04-044Apollo Endosurgery, Inc. (APEN)Disposition to issuer (D): 335,330 · Disposition to issuer (D): 150,000 (derivative) · Disposition to issuer (D): 120,834 (derivative)EDGAR
2022-11-044Apollo Endosurgery, Inc. (APEN)Tax withholding (F): 15,060 @ $6.46EDGAR
2022-08-054Apollo Endosurgery, Inc. (APEN)Tax withholding (F): 6,190 @ $6.46EDGAR
2022-06-164Apollo Endosurgery, Inc. (APEN)Grant/award (A): 88,900 @ $0 · Grant/award (A): 120,834 (derivative) @ $0EDGAR
2022-03-014Apollo Endosurgery, Inc. (APEN)Purchase (P): 15,000 @ $5.48 · Purchase (P): 15,000 @ $5.66 · Purchase (P): 10,000 @ $6.20EDGAR
2021-08-114Apollo Endosurgery, Inc. (APEN)Purchase (P): 25,000 @ $8.75 · Grant/award (A): 120,000 @ $0 · Grant/award (A): 80,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $8.69EDGAR
2021-03-104Alphatec Holdings, Inc. (ATEC)Sale (S): 7,000 @ $16.69EDGAR
2021-02-184Alphatec Holdings, Inc. (ATEC)Sale (S): 25,000 @ $16.28EDGAR
2020-08-134Alphatec Holdings, Inc. (ATEC)Sale (S): 5,000 @ $6.42EDGAR
2020-08-064Alphatec Holdings, Inc. (ATEC)Sale (S): 8,929 @ $5.03EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1449439 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs